These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3362855)

  • 21. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.
    Barchan D; Souroujon MC; Im SH; Antozzi C; Fuchs S
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8086-91. PubMed ID: 10393952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor.
    Papanastasiou D; Poulas K; Kokla A; Tzartos SJ
    J Neuroimmunol; 2000 May; 104(2):124-32. PubMed ID: 10713351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.
    Schwimmbeck PL; Dyrberg T; Drachman DB; Oldstone MB
    J Clin Invest; 1989 Oct; 84(4):1174-80. PubMed ID: 2551924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR data.
    Orlewski P; Marraud M; Cung MT; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ
    Biopolymers; 1996; 40(5):419-32. PubMed ID: 9062066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects.
    Moiola L; Karachunski P; Protti MP; Howard JF; Conti-Tronconi BM
    J Clin Invest; 1994 Mar; 93(3):1020-8. PubMed ID: 7510715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies as site-specific probes for the acetylcholine-receptor delta-subunit tyrosine and serine phosphorylation sites.
    Tzartos SJ; Kouvatsou R; Tzartos E
    Eur J Biochem; 1995 Mar; 228(2):463-72. PubMed ID: 7705363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for unpredicted transmembrane domains in acetylcholine receptor subunits.
    Criado M; Hochschwender S; Sarin V; Fox JL; Lindstrom J
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2004-8. PubMed ID: 3856878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.
    Karachunski PI; Ostlie N; Conti-Tronconi BM; Bellone M
    Immunology; 1994 May; 82(1):22-7. PubMed ID: 7519170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH; Macklin KD; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies.
    Tzartos SJ; Seybold ME; Lindstrom JM
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):188-92. PubMed ID: 6948300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Auto-antibodies against acetylcholine receptors in myasthenia gravis].
    Fabien N; Huchet FX; Sanmarco M; Dubucquoi S; Wagner S; Yamamoto AM
    Presse Med; 2001 Oct; 30(28):1414-8. PubMed ID: 11688208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.